Matches in SemOpenAlex for { <https://semopenalex.org/work/W1770956158> ?p ?o ?g. }
- W1770956158 endingPage "113" @default.
- W1770956158 startingPage "93" @default.
- W1770956158 abstract "To present proof-of-principle application for employing micro(mi)RNAs as diagnostic markers for colon cancer, we carried out global microarray expression studies on stool samples obtained from fifteen individuals (three controls, and three each with TNM stage 0-1, stage 2, stage 3, and stage 4 colon cancer), using Affymetrix GeneChip miRNA 3.0 Array, to select for a panel of miRNA genes for subsequent focused semi-quantitative polymerase chain reaction (PCR) analysis studies. Microarray results showed 202 preferentially expressed miRNA genes that were either increased (141 miRNAs), or reduced (61 miRNAs) in expression. We then conducted a stem-loop reverse transcriptase (RT)-TaqMan® minor groove binding (MGB) probes, followed by a modified qPCR expression study on 20 selected miRNAs. Twelve of the miRNAs exhibited increased and 8 decreased expression in stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic (TNM) stage 0-1, 10 with stage 2, five with stage 3, and 5 with stage 4 colon cancer) to quantitatively monitor miRNA changes at various TNM stages of colon cancer progression. We also used laser-capture microdissection (LCM) of colon mucosal epithelial tissue samples (three control samples, and three samples from each of the four stages of colon cancer, for a total of 15 samples) to find concordance or lack thereof with stool findings. The reference housekeeping pseudogene-free ribosomal gene (18S rRNA), which shows little variation in expression, was employed as a normalization standard for relative PCR quantification. Results of the PCR analyses confirmed that twelve miRNAs (miR-7, miR-17, miR-20a, miR-21, miR-92a, miR-96, miR-106a, miR-134, miR-183, miR-196a, miR-199a-3p and miR214) had an increased expression in the stool of patients with colon cancer, and that later TNM carcinoma stages exhibited a more pronounced expression than did adenomas. On the other hand, eight miRNAs (miR-9, miR-29b, miR-127-5p, miR-138, miR-143, miR-146a, miR-222 and miR-938) had decreased expression in the stool of patients with colon cancer, which was also more pronounced from early to later TNM stages. Results from colon mucosal tissues were similar to those from stool samples, although with more apparent changes in expression. Cytological studies on purified stool colonocytes that employed Giemsa staining showed 80% sensitivity for detecting tumor cells in stool smears. The performance characteristics of the test confirmed that stool is a medium well-suited for colon cancer screening, and that the quantitative changes in the expression of few mature miRNA molecules in stool associated with colon cancer progression provided for more sensitive and specific non-invasive diagnostic markers than tests currently available on the market. Thus, a larger prospective and properly randomized validation study of control individuals and patients exhibiting various stages of colon cancer progression (TNM stages 0-IV) is now needed in order to standardize test conditions, and provide a means for determining the true sensitivity and specificity of a miRNA screening approach in stool for the non-invasive detection of colon cancer, particularly at an early stage (0-I). Eventually, we will develop a chip to enhance molecular screening for colon cancer, as has been accomplished for the detection of genetically-modified organisms (GMOs) in foods." @default.
- W1770956158 created "2016-06-24" @default.
- W1770956158 creator A5000786779 @default.
- W1770956158 creator A5010847677 @default.
- W1770956158 creator A5012133031 @default.
- W1770956158 creator A5016117608 @default.
- W1770956158 creator A5017313075 @default.
- W1770956158 creator A5050571325 @default.
- W1770956158 creator A5051945540 @default.
- W1770956158 creator A5052104524 @default.
- W1770956158 creator A5055703437 @default.
- W1770956158 creator A5068100232 @default.
- W1770956158 creator A5081369976 @default.
- W1770956158 date "2013-06-07" @default.
- W1770956158 modified "2023-09-27" @default.
- W1770956158 title "Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle." @default.
- W1770956158 cites W1549733517 @default.
- W1770956158 cites W1577577364 @default.
- W1770956158 cites W1668716796 @default.
- W1770956158 cites W172983644 @default.
- W1770956158 cites W1949810991 @default.
- W1770956158 cites W1966402141 @default.
- W1770956158 cites W1967007963 @default.
- W1770956158 cites W1969738372 @default.
- W1770956158 cites W1974614205 @default.
- W1770956158 cites W1982113893 @default.
- W1770956158 cites W1984646383 @default.
- W1770956158 cites W1996962491 @default.
- W1770956158 cites W2000170100 @default.
- W1770956158 cites W2002995168 @default.
- W1770956158 cites W2006797972 @default.
- W1770956158 cites W2010215928 @default.
- W1770956158 cites W201118155 @default.
- W1770956158 cites W2015213611 @default.
- W1770956158 cites W2015701811 @default.
- W1770956158 cites W2017426710 @default.
- W1770956158 cites W2023458939 @default.
- W1770956158 cites W2025492442 @default.
- W1770956158 cites W2026022449 @default.
- W1770956158 cites W2039606711 @default.
- W1770956158 cites W2040303388 @default.
- W1770956158 cites W2046632036 @default.
- W1770956158 cites W2048512518 @default.
- W1770956158 cites W2054838338 @default.
- W1770956158 cites W2062823747 @default.
- W1770956158 cites W2068380327 @default.
- W1770956158 cites W2068639756 @default.
- W1770956158 cites W2075329854 @default.
- W1770956158 cites W2078829607 @default.
- W1770956158 cites W2080067076 @default.
- W1770956158 cites W2081906991 @default.
- W1770956158 cites W2083623143 @default.
- W1770956158 cites W2086016395 @default.
- W1770956158 cites W2087178629 @default.
- W1770956158 cites W2089591810 @default.
- W1770956158 cites W2090590443 @default.
- W1770956158 cites W2094229819 @default.
- W1770956158 cites W2096526848 @default.
- W1770956158 cites W2097233439 @default.
- W1770956158 cites W2099206288 @default.
- W1770956158 cites W2100920004 @default.
- W1770956158 cites W2105644547 @default.
- W1770956158 cites W2105696702 @default.
- W1770956158 cites W2107277218 @default.
- W1770956158 cites W2109847775 @default.
- W1770956158 cites W2109970382 @default.
- W1770956158 cites W2110065044 @default.
- W1770956158 cites W2113551318 @default.
- W1770956158 cites W2120785986 @default.
- W1770956158 cites W2122598723 @default.
- W1770956158 cites W2123099342 @default.
- W1770956158 cites W2124573195 @default.
- W1770956158 cites W2126398309 @default.
- W1770956158 cites W2128077526 @default.
- W1770956158 cites W2131360646 @default.
- W1770956158 cites W2131589770 @default.
- W1770956158 cites W2133768293 @default.
- W1770956158 cites W2135007926 @default.
- W1770956158 cites W2135810600 @default.
- W1770956158 cites W2135836598 @default.
- W1770956158 cites W2137350216 @default.
- W1770956158 cites W2137658327 @default.
- W1770956158 cites W2139069614 @default.
- W1770956158 cites W2140491861 @default.
- W1770956158 cites W2140533693 @default.
- W1770956158 cites W2141935490 @default.
- W1770956158 cites W2144805183 @default.
- W1770956158 cites W2148250104 @default.
- W1770956158 cites W2148642135 @default.
- W1770956158 cites W2150536104 @default.
- W1770956158 cites W2153295719 @default.
- W1770956158 cites W2154273881 @default.
- W1770956158 cites W2158217645 @default.
- W1770956158 cites W2159851582 @default.
- W1770956158 cites W2161222316 @default.
- W1770956158 cites W2161968856 @default.
- W1770956158 cites W2162066487 @default.
- W1770956158 cites W2163074585 @default.